An ANA, or antinuclear antibody, is an antibody that mistakenly attacks your own cells instead of fighting infections. The term comes up most often in the context of a blood test: the ANA test, which checks whether these self-targeting antibodies are present in your blood. Doctors order it when they suspect an autoimmune condition like lupus, Sjögren’s syndrome, or scleroderma.
How Antinuclear Antibodies Work
Your immune system normally produces antibodies, which are proteins designed to latch onto foreign invaders like bacteria and viruses. Antinuclear antibodies are different. They target the nucleus of your own cells, the control center that coordinates essential cell functions. When these antibodies bind to cell nuclei, they can trigger inflammation and tissue damage throughout the body.
Having some antinuclear antibodies doesn’t automatically mean you’re sick. About 7% of healthy people test positive for ANA, and the rate is higher in women (around 10%) than in men (roughly 5%). But when ANA levels are elevated and a person also has symptoms like joint pain, fatigue, skin rashes, or organ inflammation, it points toward an autoimmune condition that needs further investigation.
What the ANA Test Involves
The test itself is straightforward. A healthcare professional draws a small blood sample from a vein in your arm, and that sample goes to a lab for analysis. There’s no fasting required, and the draw takes only a few minutes. The lab examines the blood under a fluorescent microscope to see whether antibodies bind to cell nuclei and, if so, how strongly and in what pattern.
Understanding Your Titer
ANA results are reported as a titer, which is a ratio showing how many times the lab could dilute your blood and still detect the antibodies. Common titers include 1:40, 1:80, 1:160, 1:320, and 1:640. The higher the second number, the more antibodies are present.
A titer of 1:40 or 1:80 is relatively low and often seen in people without any autoimmune disease. Many labs consider a titer of 1:160 or above to be a positive result. For lupus specifically, the current classification criteria used by rheumatologists require a positive ANA at 1:80 or higher before the diagnosis is even considered. So a low-positive result on its own rarely changes anything clinically, while a high titer combined with symptoms carries much more weight.
Staining Patterns and What They Suggest
Beyond the titer, the lab also reports a staining pattern, which describes how the antibodies attach to the cell nucleus under the microscope. The four most commonly reported patterns are homogeneous, speckled, centromere, and nucleolar. Each pattern reflects a different target within the nucleus and hints at different conditions.
A homogeneous pattern, where the entire nucleus lights up evenly, is frequently associated with lupus. A speckled pattern, showing scattered dots across the nucleus, can appear in lupus, Sjögren’s syndrome, or mixed connective tissue disease. A centromere pattern is more closely linked to a limited form of scleroderma, while a nucleolar pattern may suggest systemic sclerosis. These patterns don’t confirm a diagnosis by themselves, but they help your doctor decide which follow-up tests to order.
Conditions Linked to a Positive ANA
A positive ANA test is associated with several autoimmune diseases. Lupus is the condition most people associate with ANA testing, and it’s one of the most common reasons the test is ordered. But the list extends well beyond lupus:
- Sjögren’s syndrome, which causes dry eyes and dry mouth due to immune attacks on moisture-producing glands
- Scleroderma (systemic sclerosis), involving hardening and tightening of the skin and connective tissues
- Rheumatoid arthritis, which primarily targets the joints
- Mixed connective tissue disease, a condition with overlapping features of lupus, scleroderma, and other disorders
- Polymyositis and dermatomyositis, which cause muscle weakness and, in dermatomyositis, a distinctive skin rash
Some infections, certain medications, and even normal aging can also produce a positive ANA without any underlying autoimmune disease. This is why a positive result is a starting point for investigation, not a final answer.
What Happens After a Positive Result
A positive ANA test almost always leads to more specific blood work. The most common follow-up is an ENA panel (extractable nuclear antigen panel), which is a set of four to six tests run from the same blood sample. Each test in the panel looks for a particular antibody that serves as a marker for a specific disease. For example, one antibody in the panel is strongly associated with lupus, while another points toward Sjögren’s syndrome.
Your doctor may also order a test for antibodies against double-stranded DNA, which is highly specific to lupus and helps confirm or rule out that diagnosis. Together, these follow-up tests narrow down which autoimmune condition, if any, is causing your symptoms. The whole process, from the initial ANA to follow-up testing and clinical evaluation, typically involves a referral to a rheumatologist who specializes in autoimmune diseases.
A Positive ANA Doesn’t Always Mean Disease
One of the most important things to understand about ANA testing is that a positive result, especially at a low titer, is common in people who are completely healthy. The test is sensitive by design, meaning it casts a wide net to avoid missing autoimmune conditions. The tradeoff is that it also catches many people who don’t have one. Women, older adults, and people with recent infections are all more likely to test positive without having an autoimmune disease.
If your ANA is positive but your follow-up tests come back normal and you don’t have concerning symptoms, your doctor may simply monitor you over time rather than pursue further workups. A single positive ANA, on its own, is not a diagnosis.